Levin AW

Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus, OH, USA.

6 papers · ORCID

ArticlePsilocybin

Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial.

Armstrong SB, Levin AW, Sepeda ND +5

Europe PMC2026
ArticlePsilocybin

From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.

Acero VP, Flatt TA, Gooch PM +3

Europe PMC2025
ArticlePsilocybin

The Epidemiology of Psychedelic Use Among United States Military Veterans.

Davis AK, Bates M, Lund EM +6

Europe PMC2025
ArticlePsilocybin

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.

Levin AW, Lancelotta R, Sepeda ND +6

Europe PMC2024
ArticlePsilocybin

Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.

Herrmann Z, Levin AW, Cole SP +7

Europe PMC2023
ArticlePsilocybin

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.

Davis AK, Levin AW, Nagib PB +2

Europe PMC2023